These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 1573584)
1. Oral hypoglycaemic agents: the first thirty years. Nabarro JD J R Coll Physicians Lond; 1992 Jan; 26(1):50-5. PubMed ID: 1573584 [TBL] [Abstract][Full Text] [Related]
2. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study. Savage S; Estacio RO; Jeffers B; Schrier RW Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587 [TBL] [Abstract][Full Text] [Related]
3. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus. Plosker GL; Figgitt DP Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124 [TBL] [Abstract][Full Text] [Related]
4. A study of autonomic neuropathy in diabetes mellitus in relation to its metabolic control. Gupta RC; Chittora MD; Jain A J Assoc Physicians India; 1995 Jul; 43(7):464-6. PubMed ID: 8713218 [TBL] [Abstract][Full Text] [Related]
5. Effects of insulin on body composition in patients with insulin-dependent and non-insulin-dependent diabetes. Sinha A; Formica C; Tsalamandris C; Panagiotopoulos S; Hendrich E; DeLuise M; Seeman E; Jerums G Diabet Med; 1996 Jan; 13(1):40-6. PubMed ID: 8741811 [TBL] [Abstract][Full Text] [Related]
6. Lack of knowledge of symptoms of hypoglycaemia by elderly diabetic patients. Thomson FJ; Masson EA; Leeming JT; Boulton AJ Age Ageing; 1991 Nov; 20(6):404-6. PubMed ID: 1776586 [TBL] [Abstract][Full Text] [Related]
7. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. UK Hypoglycaemia Study Group Diabetologia; 2007 Jun; 50(6):1140-7. PubMed ID: 17415551 [TBL] [Abstract][Full Text] [Related]
9. Impact of the use of anti-diabetic drugs on survival of diabetic dialysis patients: a 5-year retrospective cohort study in Taiwan. Hsiao PJ; Wu KL; Chiu SH; Chan JS; Lin YF; Wu CZ; Wu CC; Kao S; Fang TC; Lin SH; Chen JS Clin Exp Nephrol; 2017 Aug; 21(4):694-704. PubMed ID: 27599981 [TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of addition of oral spray insulin (Oralin) on insulin secretion and metabolic control in subjects with type 2 diabetes mellitus suboptimally controlled on oral hypoglycemic agents. Guevara-Aguirre J; Guevara M; Saavedra J; Mihic M; Modi P Diabetes Technol Ther; 2004 Feb; 6(1):1-8. PubMed ID: 15000763 [TBL] [Abstract][Full Text] [Related]
11. [Incidence of severe hypoglycemia in relation to metabolic control and patient knowledge]. Ratzmann KP; Schimke E Med Klin (Munich); 1995 Oct; 90(10):557-61. PubMed ID: 7500918 [TBL] [Abstract][Full Text] [Related]
12. Occurrence of low blood glucose concentrations during the afternoon in type 2 (non-insulin-dependent) diabetic patients on oral hypoglycaemic agents: importance of blood glucose monitoring. Trovati M; Burzacca S; Mularoni E; Massucco P; Cavalot F; Mattiello L; Anfossi G Diabetologia; 1991 Sep; 34(9):662-7. PubMed ID: 1955099 [TBL] [Abstract][Full Text] [Related]
13. HypoAware: development and pilot study of a brief and partly web-based psychoeducational group intervention for adults with Type 1 and insulin-treated Type 2 diabetes and problematic hypoglycaemia. Rondags SM; de Wit M; Snoek FJ Diabet Med; 2016 Feb; 33(2):184-91. PubMed ID: 26234919 [TBL] [Abstract][Full Text] [Related]
14. Self-monitoring of blood glucose in people with type 1 and type 2 diabetes living in France: the Entred study 2001. Lecomte P; Romon I; Fosse S; Simon D; Fagot-Campagna A Diabetes Metab; 2008 Jun; 34(3):219-26. PubMed ID: 18343703 [TBL] [Abstract][Full Text] [Related]
15. Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study. Donnelly LA; Morris AD; Frier BM; Ellis JD; Donnan PT; Durrant R; Band MM; Reekie G; Leese GP; Diabet Med; 2005 Jun; 22(6):749-55. PubMed ID: 15910627 [TBL] [Abstract][Full Text] [Related]
16. [Identification of factors predicting early evolution of secondary oral hypoglycaemic agent failure and evaluation of clinical standards applied by primary care physicians during qualification to insulin therapy of patients with type 2 diabetes]. Machoy M Ann Acad Med Stetin; 2004; 50(2):29-39. PubMed ID: 16529163 [TBL] [Abstract][Full Text] [Related]
17. Chronic diabetic complications in patients with MODY3 diabetes. Isomaa B; Henricsson M; Lehto M; Forsblom C; Karanko S; Sarelin L; Häggblom M; Groop L Diabetologia; 1998 Apr; 41(4):467-73. PubMed ID: 9562352 [TBL] [Abstract][Full Text] [Related]
18. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM. Kanc K; Janssen MM; Keulen ET; Jacobs MA; Popp-Snijders C; Snoek FJ; Heine RJ Diabetologia; 1998 Mar; 41(3):322-9. PubMed ID: 9541173 [TBL] [Abstract][Full Text] [Related]
19. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. Partanen J; Niskanen L; Lehtinen J; Mervaala E; Siitonen O; Uusitupa M N Engl J Med; 1995 Jul; 333(2):89-94. PubMed ID: 7777034 [TBL] [Abstract][Full Text] [Related]
20. Bedtime intermediate-acting insulin in the treatment of secondary failure to oral hypoglycemic agents. Chuang LM; Lu C; Su RJ; Wu HP; Tai TY; Lin BJ J Formos Med Assoc; 1992 Feb; 91(2):185-9. PubMed ID: 1364216 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]